[Form 4] AdaptHealth Corp. Insider Trading Activity

Rhea-AI Filing Summary

David S. Williams III, a director of AdaptHealth Corp. (AHCO), sold 8,200 shares on 08/22/2025 at a weighted average price of $9.73 per share. The filing shows the reported sales occurred in multiple transactions at prices ranging from $9.60 to $9.85, and the reporting person continues to beneficially own 50,045 shares following the transactions. The Form 4 was filed by one reporting person and signed by an attorney-in-fact, with a previously filed power of attorney incorporated by reference.

Positive

• Transparent disclosure of the share sale with weighted average price and price range provided
• Continued ownership of 50,045 shares is reported after the transactions
• Procedural compliance shown via attorney-in-fact signature and incorporated power of attorney

Negative

• Reduction in holdings by 8,200 shares reported on 08/22/2025
• Sale realized at a modest price (weighted average $9.73 per share)

Insights

Financial Analyst

TL;DR: Director sold a modest block of shares; filing documents the sale price range and remaining holdings.

The Form 4 discloses an outright sale of 8,200 common shares at a weighted average price of $9.73, with individual transaction prices between $9.60 and $9.85. The report confirms continued direct ownership of 50,045 shares post-sale. From an analytical standpoint, the filing provides clear transaction detail and preserves transparency about insider holdings and pricing; it does not include additional financial metrics or context about timing beyond the 08/22/2025 transaction date.

Corporate Governance Expert

TL;DR: Disclosure appears compliant and properly executed via power of attorney; sale details are fully footnoted.

The Form 4 is filed for one reporting person and includes an explicit footnote explaining the weighted average price and price range, plus a reference to a previously filed power of attorney. The document includes the attorney-in-fact signature block dated 08/22/2025. These elements indicate procedural compliance with Section 16 reporting requirements; the filing contains no information about any planned trading programs or contractual plans.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams David Solomon III

(Last) (First) (Middle)

6272 CONDON AVE

(Street)

LOS ANGELES CA 90056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S		8,200	D	$9.73(1)	50,045	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference

	/s/ Richard Rew, as attorney-in-fact for David S. Williams III	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AdaptHealth (AHCO) director David S. Williams III report on Form 4?

He reported selling 8,200 shares of AdaptHealth common stock on 08/22/2025 at a weighted average price of $9.73, with prices ranging $9.60 to $9.85, retaining 50,045 shares.

When were the reported transactions executed?

The transactions occurred on 08/22/2025, as indicated in the Form 4 transaction date field.

What price did the reporting person receive for the shares sold?

A weighted average price of $9.73 per share is reported, with individual sale prices ranging from $9.60 to $9.85.

How many shares does David S. Williams III own after the sale?

The filing shows 50,045 shares beneficially owned following the reported transactions.

Was the Form 4 signed directly by the reporting person?

The Form 4 includes a signature by an attorney-in-fact, Richard Rew, dated 08/22/2025, and references a previously filed power of attorney.